The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Potassium Channel Blocker Market Research Report 2024
Synopsis
Potassium Channel Blockers is a class of drugs that act by inhibition of potassium efflux through cell membranes.
The global Potassium Channel Blocker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Potassium Channel Blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Potassium Channel Blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Potassium Channel Blocker include Kineta, Sevion Therapeutics, Cono Genetix, KPI Therapeutics, Amgen, Agenus bio, Bristol-Myers Squibb, Enumeral and F-star, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Potassium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Potassium Channel Blocker.
Report Scope
The Potassium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Potassium Channel Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Potassium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kineta
Sevion Therapeutics
Cono Genetix
KPI Therapeutics
Amgen
Agenus bio
Bristol-Myers Squibb
Enumeral
F-star
GlaxoSmithKline
North Coast Bio
Novartis
Regeneron
Segment by Type
Clinical
Non-clinical
Segment by Application
Clinic
Hospital
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Potassium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Potassium Channel Blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Potassium Channel Blockers is a class of drugs that act by inhibition of potassium efflux through cell membranes.
The global Potassium Channel Blocker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Potassium Channel Blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Potassium Channel Blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Potassium Channel Blocker include Kineta, Sevion Therapeutics, Cono Genetix, KPI Therapeutics, Amgen, Agenus bio, Bristol-Myers Squibb, Enumeral and F-star, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Potassium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Potassium Channel Blocker.
Report Scope
The Potassium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Potassium Channel Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Potassium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kineta
Sevion Therapeutics
Cono Genetix
KPI Therapeutics
Amgen
Agenus bio
Bristol-Myers Squibb
Enumeral
F-star
GlaxoSmithKline
North Coast Bio
Novartis
Regeneron
Segment by Type
Clinical
Non-clinical
Segment by Application
Clinic
Hospital
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Potassium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Potassium Channel Blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Potassium Channel Blocker Market Overview
1.1 Product Overview and Scope of Potassium Channel Blocker
1.2 Potassium Channel Blocker Segment by Type
1.2.1 Global Potassium Channel Blocker Market Value Comparison by Type (2024-2030)
1.2.2 Clinical
1.2.3 Non-clinical
1.3 Potassium Channel Blocker Segment by Application
1.3.1 Global Potassium Channel Blocker Market Value by Application: (2024-2030)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Potassium Channel Blocker Market Size Estimates and Forecasts
1.4.1 Global Potassium Channel Blocker Revenue 2019-2030
1.4.2 Global Potassium Channel Blocker Sales 2019-2030
1.4.3 Global Potassium Channel Blocker Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Potassium Channel Blocker Market Competition by Manufacturers
2.1 Global Potassium Channel Blocker Sales Market Share by Manufacturers (2019-2024)
2.2 Global Potassium Channel Blocker Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Potassium Channel Blocker Average Price by Manufacturers (2019-2024)
2.4 Global Potassium Channel Blocker Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Potassium Channel Blocker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Potassium Channel Blocker, Product Type & Application
2.7 Potassium Channel Blocker Market Competitive Situation and Trends
2.7.1 Potassium Channel Blocker Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Potassium Channel Blocker Players Market Share by Revenue
2.7.3 Global Potassium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Potassium Channel Blocker Retrospective Market Scenario by Region
3.1 Global Potassium Channel Blocker Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Potassium Channel Blocker Global Potassium Channel Blocker Sales by Region: 2019-2030
3.2.1 Global Potassium Channel Blocker Sales by Region: 2019-2024
3.2.2 Global Potassium Channel Blocker Sales by Region: 2025-2030
3.3 Global Potassium Channel Blocker Global Potassium Channel Blocker Revenue by Region: 2019-2030
3.3.1 Global Potassium Channel Blocker Revenue by Region: 2019-2024
3.3.2 Global Potassium Channel Blocker Revenue by Region: 2025-2030
3.4 North America Potassium Channel Blocker Market Facts & Figures by Country
3.4.1 North America Potassium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Potassium Channel Blocker Sales by Country (2019-2030)
3.4.3 North America Potassium Channel Blocker Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Potassium Channel Blocker Market Facts & Figures by Country
3.5.1 Europe Potassium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Potassium Channel Blocker Sales by Country (2019-2030)
3.5.3 Europe Potassium Channel Blocker Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Potassium Channel Blocker Market Facts & Figures by Country
3.6.1 Asia Pacific Potassium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Potassium Channel Blocker Sales by Country (2019-2030)
3.6.3 Asia Pacific Potassium Channel Blocker Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Potassium Channel Blocker Market Facts & Figures by Country
3.7.1 Latin America Potassium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Potassium Channel Blocker Sales by Country (2019-2030)
3.7.3 Latin America Potassium Channel Blocker Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Potassium Channel Blocker Market Facts & Figures by Country
3.8.1 Middle East and Africa Potassium Channel Blocker Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Potassium Channel Blocker Sales by Country (2019-2030)
3.8.3 Middle East and Africa Potassium Channel Blocker Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Potassium Channel Blocker Sales by Type (2019-2030)
4.1.1 Global Potassium Channel Blocker Sales by Type (2019-2024)
4.1.2 Global Potassium Channel Blocker Sales by Type (2025-2030)
4.1.3 Global Potassium Channel Blocker Sales Market Share by Type (2019-2030)
4.2 Global Potassium Channel Blocker Revenue by Type (2019-2030)
4.2.1 Global Potassium Channel Blocker Revenue by Type (2019-2024)
4.2.2 Global Potassium Channel Blocker Revenue by Type (2025-2030)
4.2.3 Global Potassium Channel Blocker Revenue Market Share by Type (2019-2030)
4.3 Global Potassium Channel Blocker Price by Type (2019-2030)
5 Segment by Application
5.1 Global Potassium Channel Blocker Sales by Application (2019-2030)
5.1.1 Global Potassium Channel Blocker Sales by Application (2019-2024)
5.1.2 Global Potassium Channel Blocker Sales by Application (2025-2030)
5.1.3 Global Potassium Channel Blocker Sales Market Share by Application (2019-2030)
5.2 Global Potassium Channel Blocker Revenue by Application (2019-2030)
5.2.1 Global Potassium Channel Blocker Revenue by Application (2019-2024)
5.2.2 Global Potassium Channel Blocker Revenue by Application (2025-2030)
5.2.3 Global Potassium Channel Blocker Revenue Market Share by Application (2019-2030)
5.3 Global Potassium Channel Blocker Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Kineta
6.1.1 Kineta Corporation Information
6.1.2 Kineta Description and Business Overview
6.1.3 Kineta Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Kineta Potassium Channel Blocker Product Portfolio
6.1.5 Kineta Recent Developments/Updates
6.2 Sevion Therapeutics
6.2.1 Sevion Therapeutics Corporation Information
6.2.2 Sevion Therapeutics Description and Business Overview
6.2.3 Sevion Therapeutics Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sevion Therapeutics Potassium Channel Blocker Product Portfolio
6.2.5 Sevion Therapeutics Recent Developments/Updates
6.3 Cono Genetix
6.3.1 Cono Genetix Corporation Information
6.3.2 Cono Genetix Description and Business Overview
6.3.3 Cono Genetix Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cono Genetix Potassium Channel Blocker Product Portfolio
6.3.5 Cono Genetix Recent Developments/Updates
6.4 KPI Therapeutics
6.4.1 KPI Therapeutics Corporation Information
6.4.2 KPI Therapeutics Description and Business Overview
6.4.3 KPI Therapeutics Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KPI Therapeutics Potassium Channel Blocker Product Portfolio
6.4.5 KPI Therapeutics Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Potassium Channel Blocker Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Agenus bio
6.6.1 Agenus bio Corporation Information
6.6.2 Agenus bio Description and Business Overview
6.6.3 Agenus bio Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Agenus bio Potassium Channel Blocker Product Portfolio
6.6.5 Agenus bio Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Potassium Channel Blocker Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Enumeral
6.8.1 Enumeral Corporation Information
6.8.2 Enumeral Description and Business Overview
6.8.3 Enumeral Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Enumeral Potassium Channel Blocker Product Portfolio
6.8.5 Enumeral Recent Developments/Updates
6.9 F-star
6.9.1 F-star Corporation Information
6.9.2 F-star Description and Business Overview
6.9.3 F-star Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.9.4 F-star Potassium Channel Blocker Product Portfolio
6.9.5 F-star Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GlaxoSmithKline Potassium Channel Blocker Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 North Coast Bio
6.11.1 North Coast Bio Corporation Information
6.11.2 North Coast Bio Potassium Channel Blocker Description and Business Overview
6.11.3 North Coast Bio Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.11.4 North Coast Bio Potassium Channel Blocker Product Portfolio
6.11.5 North Coast Bio Recent Developments/Updates
6.12 Novartis
6.12.1 Novartis Corporation Information
6.12.2 Novartis Potassium Channel Blocker Description and Business Overview
6.12.3 Novartis Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novartis Potassium Channel Blocker Product Portfolio
6.12.5 Novartis Recent Developments/Updates
6.13 Regeneron
6.13.1 Regeneron Corporation Information
6.13.2 Regeneron Potassium Channel Blocker Description and Business Overview
6.13.3 Regeneron Potassium Channel Blocker Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Regeneron Potassium Channel Blocker Product Portfolio
6.13.5 Regeneron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Potassium Channel Blocker Industry Chain Analysis
7.2 Potassium Channel Blocker Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Potassium Channel Blocker Production Mode & Process
7.4 Potassium Channel Blocker Sales and Marketing
7.4.1 Potassium Channel Blocker Sales Channels
7.4.2 Potassium Channel Blocker Distributors
7.5 Potassium Channel Blocker Customers
8 Potassium Channel Blocker Market Dynamics
8.1 Potassium Channel Blocker Industry Trends
8.2 Potassium Channel Blocker Market Drivers
8.3 Potassium Channel Blocker Market Challenges
8.4 Potassium Channel Blocker Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
